首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   617篇
  免费   31篇
  国内免费   2篇
耳鼻咽喉   2篇
儿科学   55篇
妇产科学   3篇
基础医学   62篇
口腔科学   13篇
临床医学   78篇
内科学   157篇
皮肤病学   21篇
神经病学   4篇
特种医学   140篇
外科学   19篇
综合类   10篇
预防医学   24篇
眼科学   4篇
药学   34篇
肿瘤学   24篇
  2022年   1篇
  2021年   6篇
  2020年   1篇
  2019年   2篇
  2018年   10篇
  2017年   4篇
  2016年   6篇
  2015年   10篇
  2014年   14篇
  2013年   19篇
  2012年   11篇
  2011年   16篇
  2010年   23篇
  2009年   22篇
  2008年   13篇
  2007年   9篇
  2006年   14篇
  2005年   10篇
  2004年   10篇
  2003年   11篇
  2002年   6篇
  2001年   7篇
  2000年   4篇
  1999年   4篇
  1998年   37篇
  1997年   49篇
  1996年   46篇
  1995年   36篇
  1994年   20篇
  1993年   22篇
  1992年   10篇
  1991年   13篇
  1990年   7篇
  1989年   17篇
  1988年   28篇
  1987年   21篇
  1986年   23篇
  1985年   14篇
  1984年   6篇
  1983年   5篇
  1982年   6篇
  1981年   14篇
  1980年   6篇
  1979年   5篇
  1978年   8篇
  1977年   9篇
  1976年   5篇
  1975年   9篇
  1974年   1篇
排序方式: 共有650条查询结果,搜索用时 15 毫秒
1.

Background

Intramedullary nailing is considered a “gold standard” for treatment of tibial shaft fractures. However, some types of fractures are typically considered as “difficult for nailing”. This group includes the periarticular fractures, fractures of both bones at the same level, comminuted and segmental fractures of the tibia. Fixator-assisted nailing (FAN) is an effective method treatment of these types of fractures. The main requirements for the ideal reduction device are an ease of its installation and an ability of multiplanar fracture reduction. Fixator-assisted nailing (FAN) with the use of two perpendicular to each other monolateral tubular frames perfectly meets these requirements. In this study we present this new surgical technique and the analysis of first 30 cases.

Methods

A prospective analysis was conducted for 30 patients with “difficult for nailing” tibial fractures treated with fixator-assisted nailing in our institution between September 1st, 2017, and March 1st, 2018. The duration of surgery and its different stages, the time of fluoroscopy, difficulties encountered during surgery, were analyzed. Clinical and radiological methods were used to evaluated reduction quality.

Results

In all 30 cases the acceptable reduction was achieved. The mean duration of the surgical procedure was 73.7?±?3?min. The mean duration of fluoroscopy 85.9?±?4.8?s. In 7 cases we faced with technical difficulties, which were successfully addressed.

Conclusion

The described technique of FAN is an effective method for the treatment of “difficult for nailing” tibial fractures. Future multi-centered studies with a larger number of patients are needed to validate our results.  相似文献   
2.
3.
4.
5.
6.
Systemic non‐biologic agents have long been in clinical use in medicine – often with considerable efficacy, albeit with some adverse effects – as with all medications. With the advent of biologic agents, all of which currently are restricted to systemic use, there is a growing need to ensure which agents have the better therapeutic ratio. The non‐biologic agents (NBAs) include a range of agents, most especially the corticosteroids (corticosteroids). This study reviews the corticosteroids in systemic use in management of orofacial mucocutaneous diseases; subsequent studies discuss corticosteroid‐sparing agents used in the management of orofacial diseases, such as calcineurin inhibitors used to produce immunosuppression; purine synthetase inhibitors; and cytotoxic and other immunomodulatory agents.  相似文献   
7.
8.
9.
10.
Prior case reports and observational studies indicate that intravenous immune globulin (IVIg) products may cause thromboembolic events (TEEs), leading the FDA to require a boxed warning in 2013. The effect of IVIg treatment on the risk of serious TEEs (acute myocardial infarction, ischemic stroke, or venous thromboembolism) was assessed using adverse event data reported in randomized controlled trials (RCTs) of IVIg. RCTs of IVIg in adult patients from 1995 to 2015 were identified from Pubmed, Embase, ClinicalTrials.Gov , and two large prior reviews of IVIg's therapeutic applications. Trials at high risk of detection or reporting bias for serious adverse events were excluded. 31 RCTs with a total of 4,129 participants (2,318 IVIg‐treated, 1,811 control) were eligible for quantitative synthesis. No evidence was found of increased TEE risk among IVIg‐treated patients compared with control patients (odds ratio = 1.10, 95% CI: 0.44, 2.88; risk difference = 0.0%, 95% CI: ?0.7%, 0.7%, I2 = 0%). No significant increase in risk was found when arterial and venous TEEs were analyzed as separate endpoints. Trial publications provided little specific information concerning the methods used to ascertain potential adverse events. Care should be taken in extrapolating the results to patients with higher baseline risks of TEE. Am. J. Hematol. 91:594–605, 2016. © 2016 Wiley Periodicals, Inc.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号